Highly efficient total synthesis of Δ12-PGJ2, 15-deoxy-Δ12,14-PGJ2, and their analogues

Tetrahedron

Volumn 62, Issue 14, 2006, Pages 3329-3343

  Acharya, Hukum P ^a   Kobayashi, Yuichi ^a  

^a TOKYO INSTITUTE OF TECHNOLOGY   (Japan)

Author keywords

12 PGJ2; 15 Deoxy 12,14 PGJ2; Aldol reaction; Cyclopentenone; Palladium; PPAR

Indexed keywords

PALLADIUM; PROSTAGLANDIN DERIVATIVE;

ALDOL REACTION; ARTICLE; CATALYSIS; DRUG SYNTHESIS; EPOXIDATION; PRIORITY JOURNAL;

EID: 33644893966     PISSN: 00404020     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tet.2006.01.051     Document Type: Article

References (57)

1. F.A. Fitzpatrick, and M.A. Wynalda J. Biol. Chem. 258 1983 11713 11718
2. Y. Hirata, H. Hayashi, S. Ito, Y. Kikawa, M. Ishibashi, M. Sudo, H. Miyazaki, M. Fukushima, S. Narumaya, and O. Hayashi J. Biol. Chem. 263 1988 16619 16625
3. P. Tontonoz, E. Hu, and B.M. Spielgelman Cell 79 1994 1147 1156
4. B.M. Forman, P. Tontonoz, J. Chen, R.P. Brun, B.M. Spiegelman, and R.M. Evans Cell 83 1995 803 812
5. S.A. Kliewer, J.M. Lenhard, T.M. Wilson, I. Patel, D.C. Morris, and J.M. Lehmann Cell 83 1995 813 819
6. C.E. Clay, A.M. Namen, A.N. Fonteh, G. Atsumi, K.P. High, and F.H. Chilton Prostaglandins Other Lipid Mediat. 62 2000 23 32
7. R.T. Sauer Nature 347 1990 514 515
8. Reviews: (a) D. Bishop-Bailey, and J. Wray Prostaglandins Other Lipid Mediat. 71 2003 1 22
9. D.S. Straus, and C.K. Glass Med. Res. Rev. 21 2001 185 210
10. I. Dassault, and B.M. Forman Prostaglandins Other Lipid Mediat. 62 2000 1 13
11. S. Narumiya, and M. Fukushima J. Pharmacol. Exp. Ther. 239 1986 500 505
12. S. Narumiya, K. Ohno, M. Fujiwara, and M. Fukushima J. Pharmacol. Exp. Ther. 239 1986 506 511
13. S. Narumiya, K. Ohno, M. Fukushima, and M. Fujiwara J. Pharmacol. Exp. Ther. 242 1987 306 311
14. S. Rocchi, and J. Auwerx Ann. Med. 10 1999 342 351
15. S. Kersten, B. Desvergne, and W. Wahli Nature 405 2000 421 425
16. M. Ricote, A.C. Li, T.M. Wilson, C.J. Kelly, and C.K. Glass Nature 391 1998 79 82
17. C. Jiang, A.T. Ting, and B. Seed Nature 391 1998 82 86
18. A. Rossi, P. Kapahi, G. Natoli, T. Takahashi, Y. Chen, M. Karin, and M.G. Santoro Nature 403 2000 103 108
19. H. Sasaki, and M. Fukushima Anti-Cancer Drug 5 1994 131 138
20. N. Ohtani-Fujita, M. Nakanishi, N. Nakanishi, S. Dao, and T. Sasaki Biochem. Biophys. Res. Commun. 251 1998 648 652
21. K. Suzuki, F. Shoko, and M. Uyeda Biosci., Biotechnol., Biochem. 62 1998 2073 2075
22. K.M. Maxey, E. Hessler, J. MacDonald, and L. Hitchingham Prostaglandins Other Lipid Mediat. 62 2000 15 21
23. 13
24. Wakatsuki, H,; Yamoto, T.; Hashimoto, S. Eur. Pat. Appl., EP97023, 1983; Chem. Abstr. 1984, 100, 174519.
25. J.F. Bickley, V. Jadhav, S.M. Roberts, M.G. Santoro, A. Steiner, and P.W. Sutton Synlett 2003 1170 1174
26. J. Meinwald, S.S. Labana, and M.S. Chadha J. Am. Chem. Soc. 85 1963 582 585
27. K.M. Brummond, P.C. Sill, and H. Chen Org. Lett. 6 2004 149 152
28. H.P. Acharya, and Y. Kobayashi Tetrahedron Lett. 45 2004 1199 1202
29. 11
30. D.R. Deardorff, R.G. Linde II, A.M. Martin, and M.J. Shulman J. Org. Chem. 54 1989 2759 2762
31. F.-P. Montforts, I. Gesing-Zibulak, W. Grammenos, M. Schneider, and K. Laumen Helv. Chim. Acta 72 1989 1852 1859
32. E.J. Corey, and P.L. Fuchs Tetrahedron Lett. 1972 3769 3772
33. Y. Kobayashi, K. Nakata, and T. Ainai Org. Lett. 7 2005 183 186
34. T. Ainai, M. Ito, and Y. Kobayashi Tetrahedron Lett. 44 2003 3983 3986
35. β-Hydride elimination is probably the reason, though we did not obtain any evidence for the production of 3-cyclopentenon.
36. T. Sugai, and K. Mori Synthesis 1988 19 22
37. K. Laumen, and M.P. Schneider J. Chem. Soc., Chem. Commun. 1986 1298 1299
38. H.J. Bestmann, W. Stransky, and O. Vostrowsky Chem. Ber. 109 1976 1694 1700
39. J. Viala, and M. Santelli Synthesis 1988 395 397
40. 13C NMR spectroscopy (δ 126.3 and 133.4), which is probably responsible for the trans olefin isomer.
41. Y. Gao, R.M. Hanson, J.M. Klunder, S.Y. Ko, H. Masamune, and K.B. Sharpless J. Am. Chem. Soc. 109 1987 5765 5780
42. T. Katsuki, and K.B. Sharpless J. Am. Chem. Soc. 102 1980 5974 5976
43. S. Kiyooka, and M.A. Hena J. Org. Chem. 64 1999 5511 5523
44. 25
45. Y. Kobayashi, M.G. Murugesh, M. Nakano, E. Takahisa, S.B. Usmani, and T. Ainai J. Org. Chem. 67 2002 7110 7123
46. 27
47. G.L. Bundy, D.R. Morton, D.C. Peterson, E.E. Nishizawa, and W.L. Miller J. Med. Chem. 26 1983 790 799
48. S. Sugiura, T. Toru, T. Tanaka, A. Hazato, N. Okamura, K. Bannai, K. Manabe, S. Kurozumi, and R. Noyori Chem. Pharm. Bull. 32 1984 4658 4661
49. J. Zhu, J.-Y. Yang, A.J.H. Klunder, Z.-Y. Liu, and B. Zwanenburg Tetrahedron 51 1995 5847 5870
50. K. Yamada, T. Arai, H. Sasai, and M. Shibasaki J. Org. Chem. 63 1998 3666 3672
51. 3 in the transition state (B ) assisted the syn elimination effectively.
52. Deprotection of the TBS group with TBAF in THF and with NBS in wet DMSO was unsuccessful.
53. The stereochemistry of the newly formed olefin at C(13) was assigned by the chemical shift of the C(13)-H: (E)-isomer 31, δ 6.87 (d, J=11 Hz); (Z)-isomer 34, δ 6.43 (d, J=11 Hz).
54. The corresponding alcohol is synthesized in racemic form with low product selectivity in low yield: H. Mayr, and B. Grubmüller Angew. Chem., Int. Ed. Engl. 17 1978 130 131
55. K. Laumen, and M. Schneider Tetrahedron Lett. 25 1984 5875 5878
56. Y.-F. Wang, C.-S. Chen, G. Girdaukas, and C.J. Sih J. Am. Chem. Soc. 106 1984 3695 3696
57. D.R. Deardorff, C.Q. Windham, and C.L. Craney Organic Syntheses Collect. Vol. 9 1998 Wiley New York pp 487-493